Table 1.
Characteristics | GSE62254 | GSE26253 | ||
---|---|---|---|---|
Number of patients | Percentage (%) | Number of patients | Percentage (%) | |
Number of patients | 273 | 365 | ||
Gender | ||||
Male | 186 | 68.1 | 239 | 65.5 |
Female | 87 | 31.9 | 126 | 34.5 |
Age | ||||
≤60 | 104 | 38.1 | 276 | 75.6 |
>60 | 169 | 61.9 | 89 | 24.4 |
Depth of invasion | ||||
T2 | 176 | 64.5 | ||
T3+T4 | 97 | 35.5 | ||
Lymph node metastasis | ||||
N0 | 37 | 13.6 | ||
N1+N2+N3 | 236 | 86.4 | ||
TNM stage | ||||
I | 32 | 11.7 | 68 | 18.6 |
II | 163 | 59.7 | 167 | 45.8 |
III | 78 | 28.6 | 130 | 35.6 |
Lauren classification | ||||
Intestinal | 142 | 52 | 122 | 33.4 |
Diffuse | 115 | 42.1 | 232 | 63.6 |
Mixed | 16 | 5.9 | 11 | 3 |
Status of microsatellite | ||||
MSS | 206 | 75.5 | ||
MSI | 67 | 24.5 | ||
Adjuvant Chemotherapy | ||||
No | 131 | 48 | ||
Yes | 142 | 52 |
MSS, microsatellite stability; MSI, microsatellite instability.